Secondly, our results may not necessarily be validly extended to other populations with other distributions of potential effect modifiers (such as T2D status, NAFLD status and PNPLA3 allele frequencies, as indicated in our study). Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.